Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy

    NEXT STORY
    SELLAS Life Sciences Announces Review of Strategic Alternatives
    PREV STORY
    BioSig Announces Expansion of Engineering Team
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CORRECTING and REPLACING – Fluidigm Announces Second Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News

    TYME Presents Supporting Data at ESMO 2019 from TYME-88-Panc Phase II Study Demonstrating Overall Survival Trends, Well Tolerated Safety, and Quality of Life Data in Patients with Advanced Pancreatic Cancer

    author_avatar
    NASDAQ Market News

    Translational Research in Oncology (TRIO) Enrolls First Patient in Early Breast Cancer Phase 2 Trial

    author_avatar
    NASDAQ Market News